Early results from the Dog Aging Project, which is testing the anti-aging effects of the immunosuppressant drug rapamycin, suggest that the drug may improve heart function without raising blood glucose levels. The researchers are enrolling 50 dogs in the next phase of the study, which will measure heart function, activity levels, cognition and memory.
Immunosuppressant might extend healthy life spans of dogs, people
Sign up for Animal Health SmartBrief
News for animal health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.